Position in DNLI
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$3,852,958
+$1,541,893 QoQ
Shares Held
149,804
+24.5% QoQ
Ownership
0.094%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#74
of 290 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DEUTSCHE BANK AG\ holds $3,190,028,280 across 296 Biotechnology names. DNLI ranks #72 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,579,110 | $784,391,303 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
518,409 | $323,248,743 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
815,400 | $245,459,858 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
888,019 | $166,308,196 | |
| 5 | RPRX |
Royalty Pharma plc
|
2,717,951 | $152,395,510 | |
| 6 | INCY |
Incyte Corp
|
1,262,988 | $143,172,312 | |
| 7 | ARGX |
Argenx SE
|
137,335 | $127,415,291 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
249,611 | $78,899,539 |
All Filings in DNLI
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,852,958 | 149,804 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $2,311,065 | 120,368 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $1,734,969 | 105,086 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $3,014,264 | 207,594 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,902,205 | 135,969 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $2,124,245 | 156,252 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $5,662,643 | 277,853 | Shares | Defined | 2025-06-30 | |
| 2024-09-30 | $6,989,625 | 239,946 | Shares | Defined | 2025-06-26 | |
| 2024-06-30 | $5,187,347 | 223,400 | Shares | Defined | 2025-06-12 | |
| 2024-03-31 | $4,728,444 | 230,431 | Shares | Defined | 2025-06-02 | |
| 2023-12-31 | $2,475,453 | 115,352 | Shares | Defined | 2024-02-14 | |
| 2023-06-30 | $4,275,319 | 144,877 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $3,011,995 | 130,729 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $3,079,399 | 110,730 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $3,095,084 | 100,850 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,246,038 | 110,297 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $3,632,441 | 112,914 | Shares | Defined | 2022-05-13 | |
| 2021-09-30 | $5,853,005 | 116,016 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $9,180,460 | 117,038 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $3,356,849 | 58,789 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $4,346,054 | 51,887 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $1,461,038 | 40,777 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $1,006,417 | 41,622 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $1,239,688 | 70,799 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||